SCHEMBL622953

SCHEMBL622953

N#Cc1c(N)sc(C(=O)O)c1I

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPK1 P28482 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TSHR P16473 1/20 0.43
HPGD P15428 1/20 0.41
ADORA2A P29274 1/20 0.40
CISD2 Q8N5K1 1/20 0.39
KRAS P01116 1/20 0.36
BPTF Q12830 3/20 0.34
GRIA4 P48058 1/20 0.34
MEN1 O00255 1/20 0.34
BRCA1 P38398 1/20 0.34
KMT2A Q03164 1/20 0.34
FNTA P49354 2/20 0.33
FNTB P49356 2/20 0.33
GRM6 O15303 1/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10506801 0.79 ALDH1A1 (0.44) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL1313857 0.78 ALDH1A1 (0.62) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL3139290 0.78 GRIA4 (0.37) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL1551995 0.74 GRIA4 (0.57) ALDH1A1GRIA4KMT2AFNTAFNTB
SCHEMBL3138044 0.74 GRIA4 (0.52) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL5731532 0.73 GRIA4 (0.53) ALDH1A1MAPK1GRIA4KMT2AFNTA
SCHEMBL28809763 0.72 L3MBTL1 (0.61) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL17244461 0.69 GRIA2 (0.53) L3MBTL1ALDH1A1HSD17B10TSHRHPGD
SCHEMBL10508850 0.69 ADORA2A (0.49) L3MBTL1ALDH1A1MAPK1HSD17B10TSHR
SCHEMBL623972 0.67 PIK3CA (0.60) HSD17B10GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
EP-2603214-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 L3MBTL1 466/4885ALDH1A1 429/4885MAPK1 306/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 L3MBTL1 466/4885ALDH1A1 429/4885MAPK1 306/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 L3MBTL1 651/4885ALDH1A1 395/4885MAPK1 440/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 L3MBTL1 651/4885ALDH1A1 395/4885MAPK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.